BAT2: An open-source tool for flexible, automated and low cost absolute binding free energy calculations

Germano Heinzelmann,David Huggins,Michael Gilson
DOI: https://doi.org/10.26434/chemrxiv-2024-nzt5j-v2
2024-02-22
Abstract:Absolute binding free energy (ABFE) calculations with all-atom molecular dynamics (MD) have the potential to greatly reduce costs in the first stages of drug discovery. Here we introduce BAT2, the new version of the Binding Affinity Tool (BAT.py), designed to combine full automation of ABFE calculations with high-performance MD simulations, making it a potential tool for virtual screening. We describe and test several changes and new features that were incorporated into the code, such as relative restraints between the protein and the ligand instead of using fixed dummy atoms, sup- port for the OpenMM simulation engine, a merged approach to the application/release of restraints, support for cobinders and proteins with multiple chains, and many others. We also reduced the simulation times for each ABFE calculation, assessing the effect on the expected robustness and accuracy of the calculations.
Chemistry
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to introduce a new open - source tool - BAT2 (Binding Affinity Tool 2) for performing absolute binding free energy (ABFE) calculations flexibly, automatically and at a low cost. Specifically, the paper addresses the following problems: 1. **Reduce computational cost**: - Absolute binding free energy (ABFE) calculations have great potential in the early stages of drug discovery and can significantly reduce the cost of experimental high - throughput screening (HTS). However, traditional ABFE calculation methods have a high computational cost. BAT2 reduces the overall computational cost by optimizing algorithms and improving computational efficiency, thereby reducing the simulation time required for each ABFE calculation. 2. **Improve the degree of automation**: - Traditional ABFE calculations require manual construction of systems and setting of calculation parameters, which is time - consuming and error - prone. BAT2 realizes full automation of ABFE calculations, including system preparation, running and analysis, greatly reducing the need for human intervention. 3. **Enhance applicability and flexibility**: - BAT2 supports a variety of new features and improvements, enabling it to be applied to a wider range of systems. These improvements include: - Using relative constraints instead of fixed dummy atoms to constrain the relative positions between proteins and ligands. - Supporting the OpenMM simulation engine, which improves computational performance. - Combining the constraint application and release steps, reducing the number of required simulation windows and further reducing the computational cost. - Supporting multi - chain proteins and co - binding molecules (cobinders). - Supporting more water models, such as TIP3PF and OPC. - Automatically determining the number of required ions to reach the specified ion concentration. 4. **Improve the robustness and accuracy of calculations**: - The paper evaluates the impact of reducing simulation time on the robustness and accuracy of calculation results, ensuring that reliable ABFE calculation results can still be obtained while reducing computational cost. ### Summary The introduction of BAT2 aims to make ABFE calculations more practical and efficient by increasing the degree of automation, reducing cost and enhancing applicability, thus providing strong support in the early stages of drug discovery.